pillbase.ru

Zynquista

Active substance: sotagliflozin

sotagliflozin

Centralised EU authorisationWithdrawn

Marketing holder: Guidehouse Germany GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • INPEFA
    TABLET · SOTAGLIFLOZIN 400 mg/1
    70183-241
    Lexicon Pharmaceuticals, Inc.
  • INPEFA
    TABLET · SOTAGLIFLOZIN 200 mg/1
    70183-221
    Lexicon Pharmaceuticals, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-a0e0-71e2-b0f9-eed0c7f27f91,01a12097-0ff5-76dc-98dd-0a9108868ce4;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004889
Registration status
Withdrawn
ATC code
A10
Sources
  • product · EMA · EMEA/H/C/004889 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004889 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004889 · Verified 2026-10-09